Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
Duflot T, Moreau-Grangé L, Roche C, Iacob M, Wils J, Rémy-Jouet I, Cailleux AF, Leuillier M, Renet S, Li D, Morisseau C, Lamoureux F, Richard V, Prévost G, Joannidès R, Bellien J. Duflot T, et al. Among authors: morisseau c. Cardiovasc Diabetol. 2019 Mar 18;18(1):35. doi: 10.1186/s12933-019-0843-z. Cardiovasc Diabetol. 2019. PMID: 30885203 Free PMC article.
Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
Ulu A, Harris TR, Morisseau C, Miyabe C, Inoue H, Schuster G, Dong H, Iosif AM, Liu JY, Weiss RH, Chiamvimonvat N, Imig JD, Hammock BD. Ulu A, et al. Among authors: morisseau c. J Cardiovasc Pharmacol. 2013 Sep;62(3):285-97. doi: 10.1097/FJC.0b013e318298e460. J Cardiovasc Pharmacol. 2013. PMID: 23676336 Free PMC article.
Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C, Besnier M, Cassel R, Harouki N, Coquerel D, Guerrot D, Nicol L, Loizon E, Remy-Jouet I, Morisseau C, Mulder P, Ouvrard-Pascaud A, Madec AM, Richard V, Bellien J. Roche C, et al. Among authors: morisseau c. Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1020-9. doi: 10.1152/ajpheart.00465.2014. Epub 2015 Feb 27. Am J Physiol Heart Circ Physiol. 2015. PMID: 25724490 Free PMC article.
Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.
Roche C, Guerrot D, Harouki N, Duflot T, Besnier M, Rémy-Jouet I, Renet S, Dumesnil A, Lejeune A, Morisseau C, Richard V, Bellien J. Roche C, et al. Among authors: morisseau c. Prostaglandins Other Lipid Mediat. 2015 Jul;120:148-54. doi: 10.1016/j.prostaglandins.2015.04.011. Epub 2015 May 27. Prostaglandins Other Lipid Mediat. 2015. PMID: 26022136 Free PMC article.
Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction.
Savina Y, Duflot T, Bounoure F, Kotzki S, Thiebaut PA, Serreau PA, Skiba M, Picquenot JM, Cornic M, Morisseau C, Hammock B, Imbert L, Cracowski JL, Richard V, Roustit M, Bellien J. Savina Y, et al. Among authors: morisseau c. Diab Vasc Dis Res. 2019 Nov;16(6):523-529. doi: 10.1177/1479164119860215. Epub 2019 Jul 3. Diab Vasc Dis Res. 2019. PMID: 31267765 Free PMC article.
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
Kramer JS, Woltersdorf S, Duflot T, Hiesinger K, Lillich FF, Knöll F, Wittmann SK, Klingler FM, Brunst S, Chaikuad A, Morisseau C, Hammock BD, Buccellati C, Sala A, Rovati GE, Leuillier M, Fraineau S, Rondeaux J, Hernandez-Olmos V, Heering J, Merk D, Pogoryelov D, Steinhilber D, Knapp S, Bellien J, Proschak E. Kramer JS, et al. Among authors: morisseau c. J Med Chem. 2019 Sep 26;62(18):8443-8460. doi: 10.1021/acs.jmedchem.9b00445. Epub 2019 Sep 17. J Med Chem. 2019. PMID: 31436984 Free PMC article.
324 results